Renaissance Technologies (RenTech)'s HCM Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 130,200 shares of HUTCHMED (China) Limited (HCM) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2017-Q1, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in HCM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 416,652 shares. Largest reduction occurred in Q3 2022, reducing 324,700 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s HUTCHMED (China) Limited (HCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly HUTCHMED (China) Limited (HCM) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -1,862 | Reduce 1.41% | 130,200 | $10.76 |
| Q1 2026 | -2,838 | Reduce 2.10% | 132,062 | $14.96 |
| Q4 2025 | +3,900 | Add 2.98% | 134,900 | $13.33 |
| Q3 2025 | +2,000 | Add 1.55% | 131,000 | $15.75 |
| Q2 2025 | -6,200 | Reduce 4.59% | 129,000 | $15.05 |
| Q1 2025 | -53,339 | Reduce 28.29% | 135,200 | $15.04 |
| Q4 2024 | +29,239 | Add 18.35% | 188,539 | $14.41 |
| Q3 2024 | +28,000 | Add 21.33% | 159,300 | $19.53 |
| Q2 2024 | +56,200 | Add 74.83% | 131,300 | $17.12 |
| Q1 2024 | -7,200 | Reduce 8.75% | 75,100 | $16.80 |
| Q4 2023 | +30,300 | Add 58.27% | 82,300 | $18.10 |
| Q3 2023 | -3,452 | Reduce 6.23% | 52,000 | $16.94 |
| Q2 2023 | -93,800 | Reduce 62.85% | 55,452 | $0.01 |
| Q1 2023 | +59,700 | Add 66.67% | 149,252 | $0.01 |
| Q4 2022 | -2,400 | Reduce 2.61% | 89,552 | $0.01 |
| Q3 2022 | -324,700 | Reduce 77.93% | 91,952 | $8.86 |
| Q2 2022 | +416,652 | New Buy | 416,652 | $12.64 |
| Q1 2022 | -41,000 | Sold Out | 0 | $0.00 |
| Q4 2021 | -102,352 | Reduce 71.40% | 41,000 | $35.07 |
| Q3 2021 | -69,000 | Reduce 32.49% | 143,352 | $36.61 |
| Q2 2021 | -9,100 | Reduce 4.11% | 212,352 | $39.27 |
| Q1 2021 | -56,100 | Reduce 20.21% | 221,452 | $28.25 |
| Q4 2020 | -58,048 | Reduce 17.30% | 277,552 | $32.02 |
| Q3 2020 | -66,200 | Reduce 16.48% | 335,600 | $32.30 |
| Q2 2020 | +56,400 | Add 16.33% | 401,800 | $27.58 |
| Q1 2020 | +48,200 | Add 16.22% | 345,400 | $17.85 |
| Q4 2019 | +138,400 | Add 87.15% | 297,200 | $25.07 |
| Q3 2019 | +111,400 | Add 235.02% | 158,800 | $17.84 |
| Q2 2019 | +3,700 | Add 8.47% | 47,400 | $22.00 |
| Q1 2019 | -32,800 | Reduce 42.88% | 43,700 | $30.57 |
| Q4 2018 | +44,200 | Add 136.84% | 76,500 | $23.08 |
| Q3 2018 | +25,500 | Add 375.00% | 32,300 | $32.20 |
| Q2 2018 | -143,000 | Reduce 95.46% | 6,800 | $30.15 |
| Q1 2018 | +80,000 | Add 114.61% | 149,800 | $29.56 |
| Q4 2017 | -21,400 | Reduce 23.46% | 69,800 | $39.43 |
| Q3 2017 | +15,200 | Add 20.00% | 91,200 | $27.27 |
| Q2 2017 | +45,000 | Add 145.16% | 76,000 | $23.32 |
| Q1 2017 | +31,000 | New Buy | 31,000 | $19.94 |
Renaissance Technologies (RenTech)'s HUTCHMED (China) Limited Investment FAQs
Renaissance Technologies (RenTech) first purchased HUTCHMED (China) Limited (HCM) in Q1 2017, acquiring 31,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held HUTCHMED (China) Limited (HCM) for 38 quarters since Q1 2017.
Renaissance Technologies (RenTech)'s largest addition to HUTCHMED (China) Limited (HCM) was in Q2 2022, adding 416,652 shares worth $5.27 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 130,200 shares of HUTCHMED (China) Limited (HCM), valued at approximately $1.4 M.
As of the Q2 2026 filing, HUTCHMED (China) Limited (HCM) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in HUTCHMED (China) Limited (HCM) was 416,652 shares, as reported at the end of Q2 2022.